Provided by Tiger Trade Technology Pte. Ltd.

Biogen

220.77
+2.651.21%
Pre-market: 217.26-3.5100-1.59%04:00 EDT
Volume:495.44K
Turnover:109.45M
Market Cap:32.59B
PE:39.21
High:222.85
Open:218.93
Low:218.00
Close:218.12
52wk High:222.85
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.66
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.73
PE(LYR):25.12

Loading ...

Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions

TIPRANKS
·
Jul 22

Biogen is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 21

U.S. Research Roundup-colgate-palmolive, IBM, Unitedhealth

Reuters
·
Jul 21

Biogen (BIIB) Expands Its Alzheimer’s Pipeline, Is The 9% Undervaluation Still There?

Simply Wall St.
·
Jul 21

Biogen Inc. Stock Falls 2.9%, Underperforms Peers

Dow Jones
·
Jul 21

Goldman Sachs Adjusts Price Target on Biogen to $271 From $250, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biogen, Bloom, First Solar, Oklo, NNE Trending With Analysts

TIPRANKS
·
Jul 18

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Movement Alert|Biogen Rises 5.03% in Regular Trading, Canada Drug Agency Recommends Leqembi for Public Insurance Coverage

Market Focus
·
Jul 17

Eisai Limited: Cda-amc Recognizes Clinical Value of Leqembi & Recommends Public Coverage for Early Alzheimer's Disease

THOMSON REUTERS
·
Jul 16

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 16

Cardiovascular Drug Developer Braveheart, Backed by A16z and Led by Biogen's CEO, Files for Nasdaq IPO

Stock News
·
Jul 15

Biogen Names Michael Parini Chief Legal Officer Effective Aug. 3

Reuters
·
Jul 15

Biogen Appoints Michael J. Parini as Chief Legal Officer

THOMSON REUTERS
·
Jul 15

Biogen: CELIA Phase 2 Data Underpin Continued Confidence in Diranersen; Buy Rating and $256 Price Target Reiterated

TIPRANKS
·
Jul 15

Biogen Inc. Stock Slips 8.2%, Underperforms Peers

Dow Jones
·
Jul 15

IBM, Goldman Sachs, SK Hynix, Micron, Crowdstrike, Biogen, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 15

Cantor Fitzgerald Adjusts Biogen Price Target to $237 From $206

MT Newswires Live
·
Jul 15

Biogen Stock Sinks on Lackluster Alzheimer's News

Dow Jones
·
Jul 14

RBC says Biogen detailed Phase 2 results ‘leave more questions than answers’

TIPRANKS
·
Jul 14